Works matching IS 13866346 AND DT 2011 AND VI 41 AND IP 12


Results: 16
    1
    2
    3

    Primary liver tumor associated with Werner syndrome (adult progeria).

    Published in:
    Hepatology Research, 2011, v. 41, n. 12, p. 1260, doi. 10.1111/j.1872-034X.2011.00877.x
    By:
    • Okano, Hiroshi;
    • Isono, Yoshiaki;
    • Tanaka, Hiroki;
    • Ishihara, Yoshiko;
    • Matsusaki, Shimpei;
    • Aoki, Masatoshi;
    • Sase, Tomohiro;
    • Saitou, Tomonori;
    • Mukai, Katsumi;
    • Nishimura, Akira;
    • Takemoto, Minoru;
    • Yokote, Koutaro
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis.

    Published in:
    Hepatology Research, 2011, v. 41, n. 12, p. 1253, doi. 10.1111/j.1872-034X.2011.00875.x
    By:
    • Kawaguchi, Takumi;
    • Kaji, Ryohei;
    • Horiuchi, Hiroyuki;
    • Shirono, Tomotake;
    • Ishida, Yusuke;
    • Okabe, Yoshinobu;
    • Itou, Minoru;
    • Mitsuyama, Keiichi;
    • Akiba, Jun;
    • Nakashima, Osamu;
    • Yano, Hirohisa;
    • Kage, Masayoshi;
    • Harada, Masaru;
    • Sakisaka, Shotaro;
    • Sata, Michio
    Publication type:
    Article
    11

    Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy.

    Published in:
    Hepatology Research, 2011, v. 41, n. 12, p. 1145, doi. 10.1111/j.1872-034X.2011.00886.x
    By:
    • Itoh, Yoshito;
    • Nishimura, Takeshi;
    • Yamaguchi, Kanji;
    • Yokomizo, Chihiro;
    • Fujii, Hideki;
    • Minami, Masahito;
    • Nagao, Yasuyuki;
    • Sumida, Yoshio;
    • Hashimoto, Hiroaki;
    • Umemura, Atsushi;
    • Shima, Toshihide;
    • Okanoue, Takeshi;
    • Yoshikawa, Toshikazu
    Publication type:
    Article
    12

    Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.

    Published in:
    Hepatology Research, 2011, v. 41, n. 12, p. 1137, doi. 10.1111/j.1872-034X.2011.00879.x
    By:
    • Tamai, Hideyuki;
    • Shingaki, Naoki;
    • Shiraki, Tatsuya;
    • Tukuda, Hiroshi;
    • Mori, Yoshiyuki;
    • Moribata, Kosaku;
    • Enomoto, Shotaro;
    • Deguchi, Hisanobu;
    • Ueda, Kazuki;
    • Inoue, Izumi;
    • Maekita, Takao;
    • Iguchi, Mikitaka;
    • Yanaoka, Kimihiko;
    • Oka, Masashi;
    • Ichinose, Masao
    Publication type:
    Article
    13

    Acknowledgements.

    Published in:
    Hepatology Research, 2011, v. 41, n. 12, p. 1266, doi. 10.1111/j.1872-034X.2011.00940.x
    Publication type:
    Article
    14
    15
    16